- Wider reach for nutraceuticals portfolio in Europe, Turkey and Egypt
- Enhanced offering to customers
- Partnership meets customer needs in fast-moving, growth industry
Evonik has entered into an agreement with specialty chemicals distributor Safic-Alcan to provide nutraceuticals to a wider customer base. The partnership started on 1 May 2023 and enables the distribution of a full range of Evonik nutraceutical products such as AvailOm®, IN VIVO BIOTICS™ or Healthberry® to customers in Europe, Turkey and Egypt. By partnering with Safic-Alcan, Evonik can reach more customers through a network of local sales offices, enhancing its portfolio to target consumer needs in a broad range of areas such as brain, eye and heart health.
“We are excited to work with Safic-Alcan to extend our network in this fast-moving growth industry. Our partnership benefits our customers, who gain access to tailored combinations of nutraceutical ingredients and formulations,” said Maximillian Yeh, head of Health Solutions at Evonik’s Health Care business.
Founded in 1847, Safic-Alcan is a dynamic supplier of active ingredients and speciality chemicals globally. With a focus on innovation, Safic-Alcan relies on a thoroughly curated portfolio for nutraceuticals - bringing science and sustainability alongside technical expertise - to all customer projects.
“The advanced food ingredients portfolio at Evonik brings much-needed performance and innovation to the rapidly changing food supplements market. With our team of nutraceutical experts, we are committed to providing superior solutions for new product development to meet our customers' evolving needs. As a company driven by innovation, we are excited about the promising prospects offered by Evonik’s advanced food ingredients portfolio in key market segments such as immunity, nutricosmetics, and brain and cardiovascular health. We are delighted to bring this to our European, Turkish and Egyptian customers,” said Philippe Villequey, business director Development Group for Home, Personal Care & Nutraceuticals at Safic-Alcan.
Evonik offers a nutraceuticals portfolio of advanced health ingredients, formulation services and finished dosage forms. The Health Care business at Evonik is part of the company’s life sciences division, Nutrition & Care, which aims to increase its share of System Solutions from 20 percent today to more than 50 percent by 2030. System Solutions are defined as multicomponent systems tailored to a specific customer need.
Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of €18.5 billion and an operating profit (adjusted EBITDA) of €2.49 billion in 2022. Evonik goes far beyond chemistry to create innovative, profitable, and sustainable solutions for customers. About 34,000 employees work together for a common purpose: We want to improve life today and tomorrow.
About Nutrition & Care
The focus of the business of the Nutrition & Care division is on health and quality of life. It develops differentiated solutions for active pharmaceutical ingredients, medical devices, nutrition for humans and animals, personal care, cosmetics, and household cleaning. In these resilient end markets, the division generated sales of €4.24 billion in 2022 with about 5,700 employees.
Safic-Alcan is a French independent distributor of specialty chemicals headquartered in Paris La Défense (France). The Company develops and provides wide ranges of polymers, materials and additives for the rubber, coatings, adhesives, thermoplastics, polyurethane, lubricants, detergency, cosmetics, pharmaceuticals, and nutraceuticals industries. With a network of 35 offices strategically located in Europe, Turkey, the Middle East, China, the USA, Brazil, Canada and Mexico. The company represents state-of-the art manufacturers around the world. Its highly specialized sales engineers allow Safic-Alcan to provide dedicated technical expertise and high-performance solutions thus creating long term partnership with most of its principals and customers. Safic-Alcan employs more than 790 people worldwide.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.